Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-04-07 00:00:00 ET · period of report 2023-04-05 · accession 0001209191-23-023836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-07 | 2023-04-05+ | RXRX | Gibson Christopher | CEO, Dir | S - Sale+OE | $6.60 | -53.3K | 946.7K | -5% | -$351.7K |
| D | 2023-04-07 | 2023-04-05 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $2.48 | +31.2K | 960.0K | +3% | +$77.5K |
| D | 2023-04-07 | 2023-04-05 | RXRX | Gibson Christopher | CEO, Dir | G - Gift | $0.00 | -10.0K | 928.8K | -1% | $0 |
| D | 2023-04-07 | 2023-04-05 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $0.00 | -31.2K | 656.2K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-06 | S | D | 40,000 | $6.64 | 906,710 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $6.365 to $6.725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2023-04-05 | S | D | 13,327 | $6.46 | 946,710 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $6.451 to $6.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2023-04-05 | M | A | 31,250 | $2.48 | 960,037 | D | — | — | |
| 4 | Common | Class A Common Stock | 2023-04-05 | G | D | 10,000 | $0.00 | 928,787 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-04-05 | M | D | 31,250 | $0.00 | 656,250 | D | $2.48 · — to 2030-12-30 | 31,250 Class A Common Stock | (F6) The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |